![](https://i0.wp.com/glhf.org/wp-content/uploads/2020/07/Test-Tube-pic-from-stimate-re-sized.jpg?resize=668%2C335&ssl=1)
HFA and NHF Respond to Stimate Drug Recall
On July 21, CSL Behring and Ferring Pharmaceuticals announced a recall of multiple lots of Stimate (desmopressin) in the United States and in other countries around the world. The recall was prompted by the manufacturer’s discovery of out-of-specification levels of the active ingredient in the marketed product. This announcement has raised many troubling questions among national and international patient organizations and community members. HFA and NHF submitted a letter to CSL Behring and Ferring. Read more.